Terns Pharmaceuticals, Inc. Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc.

TERN

Rang în acțiuni #3581
Terns Pharmaceuticals, Inc. is a biopharmaceutical firm currently in the... Terns Pharmaceuticals, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to advancing novel small-molecule treatments. Its primary focus lies in developing both standalone agents and combination therapies to address non-alcoholic steatohepatitis (NASH) and obesity. The company's pipeline includes several key drug candidates: TERN-101, a farnesoid X receptor agonist distinguished by its liver-specific distribution and non-bile acid properties, is presently undergoing Phase IIa clinical trials for NASH. TERN-201, a vascular adhesion protein-1 inhibitor, is in Phase Ib clinical studies, also targeting NASH. Terns is also progressing TERN-501, a thyroid hormone receptor beta agonist engineered for improved liver targeting and metabolic resilience, through Phase I clinical trials for NASH. Furthermore, the company is advancing TERN-601, an oral small-molecule Glucagon-Like Peptide-1 receptor agonist program, intended for the management of NASH and various metabolic conditions, including obesity. Established in 2016, Terns Pharmaceuticals maintains its corporate headquarters in Foster City, California.
Preț acțiune
$52.95
Ultima sincronizare: 2026-05-15
Capitalizare de piață
$4.77B
Schimbare (1 zi)
0.00%
Schimbare (1 an)
552.09%
Țară
US
Tranzacționează Terns Pharmaceuticals, Inc. (TERN)

Categorie

Healthcare
Istoric al prețului acțiunii pentru Terns Pharmaceuticals, Inc. (TERN)
Cel mai mare preț de închidere: $52.95 pe 2026-05-01

Cel mai mic preț de închidere: $20.53 pe 2021-02-01
Istoric al prețului acțiunii pentru Terns Pharmaceuticals, Inc. din 2021 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) -1.17%
2025 517.55%
2024 -2.74%
2023 -12.48%
2022 13.79%
2021 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$517.02 21.29%
US
$249.01 805.82%
US
$138.33 -3.31%
AU
$882.86 5.76%
NL
$752.87 7.40%
CH